BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33569638)

  • 1. Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis.
    Fenaroli P; Maritati F; Vaglio A
    Curr Rheumatol Rep; 2021 Feb; 23(3):18. PubMed ID: 33569638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal fibrosis.
    Pipitone N; Vaglio A; Salvarani C
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):439-48. PubMed ID: 23040359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroperitoneal fibrosis: single-centre experience from 1992 to 2010, current status of knowledge and review of the international literature.
    Gómez García I; Sánchez Castaño A; Romero Molina M; Rubio Hidalgo E; García Betancourth N; Labra González R; Sampietro Crespo A; Álvarez Fernández F; Flores Herrero Á; Gómez Rodríguez A
    Scand J Urol; 2013 Oct; 47(5):370-7. PubMed ID: 23206245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Tubulo-interstitial Pyelonephritis with Retroperitoneal Fibrosis.
    Soneja M; Achintya S; Nischal N; Ranjan P; Vyas S; Arava S; Sharma SK
    J Assoc Physicians India; 2016 Jun; 64(6):71. PubMed ID: 27739273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis.
    Washino S; Hirai M; Matsuzaki A; Kobayashi Y
    Ann Nucl Med; 2010 Apr; 24(3):225-9. PubMed ID: 20112003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal fibrosis: A literature review.
    Gómez Rivas J; Quintana LM; Álvarez-Maestro M; Aguilera A; Martinez Piñeiro L; Sarikaya S
    Arch Esp Urol; 2020 Jan; 73(1):60-67. PubMed ID: 31950925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography as a tool for the 'tailored' management of retroperitoneal fibrosis: a nephro-urological experience.
    Piccoli GB; Consiglio V; Arena V; Pelosi E; Anastasios D; Ragni F; Fiori C; Cortese G; Deagostini MC; Porpiglia F; Scarpa RM
    Nephrol Dial Transplant; 2010 Aug; 25(8):2603-10. PubMed ID: 20157170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis.
    Pipitone N; Versari A; Vaglio A; Salvarani C
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S72-8. PubMed ID: 21418782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic retroperitoneal fibrosis: an update for nephrologists.
    Raglianti V; Rossi GM; Vaglio A
    Nephrol Dial Transplant; 2021 Sep; 36(10):1773-1781. PubMed ID: 33005943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis.
    Catanoso MG; Spaggiari L; Magnani L; Pipitone N; Versari A; Boiardi L; Pazzola G; Pattacini P; Salvarani C
    Clin Exp Rheumatol; 2012; 30(5):776-8. PubMed ID: 23021007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature.
    Roussel E; Callemeyn J; Van Moerkercke W
    Acta Clin Belg; 2020 Aug; 75(4):239-244. PubMed ID: 31035909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hybrid molecular imaging in retroperitoneal fibrosis: a systematic review.
    Grozdic Milojevic IT; Milojevic B; Sobic-Saranovic DP; Artiko VM
    Rheumatol Int; 2018 Feb; 38(2):179-187. PubMed ID: 28840309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4-related retroperitoneal fibrosis: a newly characterized disease.
    Lian L; Wang C; Tian JL
    Int J Rheum Dis; 2016 Nov; 19(11):1049-1055. PubMed ID: 27125330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Retroperitoneal Fibrosis.
    Vaglio A; Maritati F
    J Am Soc Nephrol; 2016 Jul; 27(7):1880-9. PubMed ID: 26860343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of retroperitoneal fibrosis responding to steroid therapy.
    Watanabe R; Ozawa A; Iseda T
    Int Braz J Urol; 2017; 43(6):1185-1189. PubMed ID: 28379669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4-Related Kidney Disease and IgG4-Related Retroperitoneal Fibrosis.
    Kawano M; Yamada K
    Semin Liver Dis; 2016 Aug; 36(3):283-90. PubMed ID: 27466797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made?
    Cohan RH; Shampain KL; Francis IR; Davenport MS; Stuart Wolf J; Marder W; Swartz RD
    Abdom Radiol (NY); 2018 May; 43(5):1204-1214. PubMed ID: 28849414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience.
    Oztas M; Altun I; Ayla AY; Cerme E; Demirdag C; Asa S; Sonmezoglu K; Ugurlu S
    Int J Rheum Dis; 2023 Sep; 26(9):1714-1721. PubMed ID: 37358327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.
    Bertagna F; Treglia G; Leccisotti L; Bosio G; Motta F; Giordano A; Giubbini R
    Jpn J Radiol; 2012 Jun; 30(5):415-21. PubMed ID: 22421932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review.
    Treglia G; Mattoli MV; Bertagna F; Giubbini R; Giordano A
    Rheumatol Int; 2013 Mar; 33(3):549-55. PubMed ID: 23124736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.